ArticleJournal of clinical medicine2019

Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy.

Byung-Hak Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.